Asthma is an important non-communicable disease. This section includes key recommendations for the World Health Organization, governments, health authorities and others.
The Global Asthma Report 2022 is the fourth in a series published in 2011, 2014 and 2018. It is a 102-page cutting edge State-of-the-Art report, with contributions from 97 experts from, 31 countries. The focus is on reducing the burden of asthma and improving asthma management. The section on the six WHO regions, includes insightful accounts.
We summarise new asthma research by the Global Asthma Network: prevalence and severity of asthma, changes over time, and how it is managed. This report is written in the third year of the COVID-19 pandemic, and we report new research about children with asthma and COVID-19. Before the pandemic many people with asthma, especially in low- and middle-income countries, were unable to access the quality-assured essential asthma medicines and care they need, and that may have worsened.
The Global Asthma Report 2022 highlights all the major issues related to prevention and management of asthma, including access to affordable essential medicines, and policy. It is an excellent tool for advocacy purposes in all countries, suggesting concrete actions for all stakeholders.
More than 1000 people per day die from asthma. Low- and middle-income countries disproportionally suffer the most severe cases. We have the tools to counter the devastating personal and economic impact of untreated and poorly managed asthma. It is time to take more action.
Asthma should be well controlled, but it is a cause of substantial disability and death worldwide. New evidence from the Global Asthma Network shows that global patterns of disease are similar across children, adolescents and adults but adolescents have the highest prevalence and severity.